GRACE KIM to Antibodies, Monoclonal
This is a "connection" page, showing publications GRACE KIM has written about Antibodies, Monoclonal.
Connection Strength
0.599
-
Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab. BMJ Open. 2025 May 12; 15(5):e094559.
Score: 0.599